TABLE 3.
Characteristics of JAL+ RBCs
| (C)(e) JAL+ |
(c)(e) JAL+ |
|
|---|---|---|
| Characteristics | Caucasian | Black persons of African descent |
| C | +W/0 | 0 |
| c | 0 | +/+W/0 |
| E | 0 | 0 |
| e | +/+W/0 | +/+W/0 |
| f | 0 | 0 |
| V | 0 | +W/0 |
| VS | 0 | +W/0 |
| hrB | +W | +W/0 |
| hrS | +W | +W/0 |
| Gene13,15 | RHCE*CeMA | RHCE*ceS(340) |
| Alloantibody | None described | Anti-c; anti-e; anti-CEST; anti-Ce15 |
| Reactivity with anti-C reagents | ||
| MS24 (Gamma-Clone, Immuncor Series 1, Ortho, SNF) MS273(SNF), polyclonal (Immucor) (DCe/ce control 3+ to 4+) | + to 2+ | 0 |
| Reactivity with anti-c reagents | ||
| S42 (Ortho), BS240 (SNF) (DCe/ce control 4+) | 0 | 3+ |
| MS33 (Immucor), RaE11 (SNF), polyclonal (Gamma, Immucor) (DCe/ce control 4+) | 0 | 1+ to 2+ |
| 951 (Gamma-Clone) (DCe/ce control 4+) | 0 | 0 |
| Reactivity with anti-e reagents | ||
| MS62 (SNF), MS63 (SNF), Gamma-Clone (MS16, MS21 and MS63) (DcE/ce control 4+) | 4+ | 2+ to 3+ |
| MS21 (SNF), MS69 (SNF), HIRO38 (SNF), HIRO41 (SNF), HIRO43 (SNF) (DcE/ce control 2+ to 3+) | 1+ | 0 |
| MS16 (Ortho Bioclone) (DcE/ce control 4+) | 1+ | 0 |
| MS16 (Immucor Series 1) (DcE/ce control 2+) | 0 | 0 |
| Polyclonal (Immucor) (DcE/ce control 4+) | 2+ | 0 to 1+W |
SNF = supernatant culture fluid containing single-clone MoAb.